Eloxx Pharmaceuticals, Inc. Deferred Offering Costs
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-09-11
- 2026-03-31: Deferred Offering Costs $800.00K.
- 2025-12-31: Deferred Offering Costs $0.00.
- 2023-09-30: Deferred Offering Costs $300.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2026-03-31 | $800.00K S-1/A · filed 2026-06-04 |
| 2025-12-31 | $0.00 S-1/A · filed 2026-06-04 |
| 2023-09-30 | $300.00K S-1 · filed 2026-09-11 |